Rubius Therapeutics reels in $120 mln

Cambridge, Massachusetts-based biotech firm Rubius Therapeutics has raised $120 million in financing. The investors included Flagship Pioneering.

21 June 2017•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.